FTV Form 4: CEO Soroye Receives New Equity Awards, Ups Stake to 206k Shares
Rhea-AI Filing Summary
Fortive Corporation (FTV) – Form 4 insider transaction
On 07/02/2025 President & CEO Olumide Soroye received a new equity compensation package that includes:
- 33,100 Restricted Stock Units (RSUs) – issued in two tranches of 14,185 and 18,915 units, both time-based; RSUs settle one-for-one in common shares.
- 100,300 stock options – two grants for 42,990 and 57,310 shares at an exercise price of $53.34; options expire 07/02/2035 with multi-year vesting schedules (50 % vests on 3rd & 4th anniversaries for one grant; 50 %, 25 %, 25 % over years 1-3 for the other).
Following the RSU grants, Soroye’s direct ownership increased to 206,130 common shares. Option grants are non-cash awards and do not affect current share count until exercised, but they add to potential future dilution.
The company notes that share totals may be adjusted after the 06/28/2025 spin-off of Ralliant Corporation.
The filing represents routine executive compensation rather than an open-market purchase; market impact is likely limited.
Positive
- Enhanced alignment: CEO now holds 206,130 shares plus options, increasing personal exposure to Fortive’s equity performance.
Negative
- Potential dilution: 100,300 new options could add to share count upon exercise, though impact is minor relative to total shares outstanding.
- Post-spin adjustment uncertainty: Share totals may change after the recent Ralliant spin-off, creating short-term disclosure noise.
Insights
TL;DR: Routine equity awards; aligns CEO incentives, minor future dilution, neutral share-price impact.
Fortive’s Compensation Committee delivered a standard long-term incentive mix of RSUs and options to CEO Olumide Soroye. The grants increase his share ownership to 206,130 shares and provide 100,300 options struck at the current market price of $53.34. Because no open-market buying occurred, there is no direct bullish signal; however, the sizeable equity stake tightens management-shareholder alignment. Dilution risk is modest (<0.08 % of diluted shares) and spread over a 10-year term. Overall, the event is governance-neutral and unlikely to move the stock materially.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 42,990 | $0.00 | -- |
| Grant/Award | Employee Stock Option (Right to Buy) | 57,310 | $0.00 | -- |
| Grant/Award | Common Stock | 14,185 | $53.34 | $757K |
| Grant/Award | Common Stock | 18,915 | $53.34 | $1.01M |
Footnotes (1)
- The Compensation Committee (the "Committee") awarded the Reporting Person Restricted Stock Units ("RSUs") effective July 2, 2025. This transaction is being reported to identify the portion of the RSUs that are subject only to time-based vesting provisions. Pursuant to the terms of the award, additional RSUs may be issued upon determination by the Committee that the corresponding performance criteria have been achieved. RSUs are payable in shares of common stock on a one-to-one basis. The number reported in this column does not reflect adjustments that are still pending as a result of the spin-off of Ralliant Corporation from the Issuer on June 28, 2025. The Committee awarded the Reporting Person RSUs effective July 2, 2025. This transaction is being reported to identify the portion of the RSUs that are subject only to time-based vesting provisions. One half of the options granted vest on each of the third and fourth anniversary of the grant date. One half of the options granted vest on the first anniversary of the grant date, and 25% of the options granted vest on each of the second and third anniversary of the grant date.
